Follow by Email

Thursday, February 7, 2013

Herablife Turning ‘Immune to Ackman’s Bad Medicine’: Shareholder $HLF

Herablife Turning ‘Immune to Ackman’s Bad Medicine’: Shareholder $HLF

Herbalife shares are up on a day when Ackman, the founder of Pershing Square Capital Management, has unleashed his latest round of questioning of the nutrition company’s business model. Such a move in the stock price hasn’t been lost on at least one of Herbalife’s shareholders.
“The market has voted with an excess of buy orders as to the invalidity of Ackman’s inquiries,” Robert Chapman, founder of Los Angeles based Chapman Capital LLC, said in an email. “Like with a virus, Herbalife stock is becoming  immune to Ackman’s bad medicine.”

No comments:

Post a Comment